Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Out of the blue growth shock sees pressure mount on Sage

SAGE (SGE) 597.8p
Loss to date: 23.9%
Original entry point: Buy at 785.5p, 21 December 2017
Sage’s (SGE) out of the blue growth shock on 13 April caught the whole market on the hop and it has caused huge damage to investors.
The shares may have fallen barely more than 8% on the day (recovering from early session declines of 20%-odd) but the stock has continued to be weak since.
The company blames sluggish recurring revenue sales and software subscriptions, with traditional licenses and services seemingly growing at their expense.
Cynics might argue how well Sage’s subscription-focused strategy is really working. However, it seems at least in part the problems have been self-inflicted judging by comments of ‘inconsistent operation execution’.
That’s two quarters running when organic revenue has failed to hit 8% targets leaving a lot to do even to catch up to lowered 7% growth rates for the full year. At least operating profit margins targets have been held at 27.5%.
The quicker Sage can remedy the situation, presuming it can, the better. Speeding up organic growth rates was a fundamental premise of our Top Picks for 2018 story.
Sage has been putting up very decent returns for shareholders for years and that suggests management deserve the benefit of the doubt.
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Big News
- JD Sports is still fighting fit
- ImmuPharma collapses on trial failure
- British Airways owner eyes takeover of Norwegian Air
- Apollo stalks FirstGroup with takeover interest
- Pound pushes to highest level since Brexit vote
- Cyber security firm Avast set for £2.8bn IPO
- Activist investor Elliott rumoured to have Micro Focus in its sights
- Costa spin-off calls at Whitbread gain momentum